Citations (75)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Jie Tao, Jiumeng Zhang, Yu Hu, Yuan Yang, Zhiyuan Gou, Ting Du, Jian Mao & Maling Gou. (2017) A conformal hydrogel nanocomposite for local delivery of paclitaxel. Journal of Biomaterials Science, Polymer Edition 28:1, pages 107-118.
Read now
Read now
Wei-kang Xing, Chuan Shao, Zhen-yu Qi, Chao Yang & Zhong Wang. (2015) The role of Gliadel wafers in the treatment of newly diagnosed GBM: a meta-analysis. Drug Design, Development and Therapy 9, pages 3341-3348.
Read now
Read now
Kaisorn L. Chaichana, Lyonell Kone, Chetan Bettegowda, Jon D. Weingart, Alessandro Olivi, Michael Lim, Alfredo Quinones-Hinojosa, Gary L. Gallia & Henry Brem. (2015) Risk of surgical site infection in 401 consecutive patients with glioblastoma with and without carmustine wafer implantation. Neurological Research 37:8, pages 717-726.
Read now
Read now
Rahul Surendra Shah, Bobak Homapour, Elizabeth Casselden, James Geoffrey Barr, Paul L. Grundy & Howard L. Brydon. (2014) Delayed post-operative haemorrhage after carmustine wafer implantation: A case series from two UK centres. British Journal of Neurosurgery 28:4, pages 488-494.
Read now
Read now
A. Gutenberg, H. C. Bock, W. Brück, L. Doerner, H. M. Mehdorn, W. Roggendorf, M. Westphal, J. Felsberg, G. Reifenberger & A. Giese. (2013) MGMT promoter methylation status and prognosis of patients with primary or recurrent glioblastoma treated with carmustine wafers. British Journal of Neurosurgery 27:6, pages 772-778.
Read now
Read now
James Geoffrey Barr & Paul L. Grundy. (2012) The effects of the NICE Technology Appraisal 121 (Gliadel and Temozolomide) on survival in high-grade glioma. British Journal of Neurosurgery 26:6, pages 818-822.
Read now
Read now
Sanjay Dixit, Mohan Hingorani, Shailendra Achawal & Ian Scott. (2011) The sequential use of carmustine wafers (Gliadel®) and post-operative radiotherapy with concomitant temozolomide followed by adjuvant temozolomide: a clinical review. British Journal of Neurosurgery 25:4, pages 459-469.
Read now
Read now
Renato V. La Rocca & H. Maximilian Mehdorn. (2009) Localized BCNU chemotherapy and the multimodal management of malignant glioma. Current Medical Research and Opinion 25:1, pages 149-160.
Read now
Read now
Articles from other publishers (67)
Pavel Burko, Giuseppa D’Amico, Ilia Miltykh, Federica Scalia, Everly Conway de Macario, Alberto J. L. Macario, Giuseppe Giglia, Francesco Cappello & Celeste Caruso Bavisotto. (2023) Molecular Pathways Implicated in Radioresistance of Glioblastoma Multiforme: What Is the Role of Extracellular Vesicles?. International Journal of Molecular Sciences 24:5, pages 4883.
Crossref
Crossref
Alexander D Josowitz, Ranjit S Bindra & W Mark Saltzman. (2022) Polymer nanocarriers for targeted local delivery of agents in treating brain tumors. Nanotechnology 34:7, pages 072001.
Crossref
Crossref
Harpinder K. Brar, Jiney Jose, Zimei Wu & Manisha Sharma. (2022) Tyrosine Kinase Inhibitors for Glioblastoma Multiforme: Challenges and Opportunities for Drug Delivery. Pharmaceutics 15:1, pages 59.
Crossref
Crossref
Yu FUJII, Toshihiro OGIWARA, Hiroto KATO, Yoshiki HANAOKA, Ridzky Firmansyah HARDIAN, Tetsuya GOTO, Kazuhiro HONGO & Tetsuyoshi HORIUCHI. (2022) Cerebral Edema Due to Chemotherapeutic Wafer Implantation for Malignant Glioma: Registry Study of Correlation with Perioperative Epileptic Seizures. Neurologia medico-chirurgica 62:7, pages 328-335.
Crossref
Crossref
Alexandre Roux, Hichem Ammar, Alessandro Moiraghi, Sophie Peeters, Marwan Baroud, Gilles Zah-Bi, Joseph Benzakoun, Eduardo Parraga, Catherine Oppenheim, Chiara Benevello, Fabrice Chretien, Pascale Varlet, Frédéric Dhermain, Edouard Dezamis, Marc Zanello & Johan Pallud. (2021) Discriminating surgical bed cysts from bacterial brain abscesses after Carmustine wafer implantation in newly diagnosed IDH-wildtype glioblastomas. Neurosurgical Review 45:2, pages 1501-1511.
Crossref
Crossref
Jiwei Cui, Yuanxin Xu, Haiyan Tu, Huacong Zhao, Honglan Wang, Liuqing Di & Ruoning Wang. (2022) Gather wisdom to overcome barriers: Well-designed nano-drug delivery systems for treating gliomas. Acta Pharmaceutica Sinica B 12:3, pages 1100-1125.
Crossref
Crossref
Ani-Simona Sevastre, Alexandra Costachi, Ligia Tataranu, Corina Brandusa, Stefan Artene, Olivian Stovicek, Oana Alexandru, Suzana Danoiu, Veronica Sfredel & Anica Dricu. (2021) Glioblastoma pharmacotherapy: A multifaceted perspective of conventional and emerging treatments (Review). Experimental and Therapeutic Medicine 22:6.
Crossref
Crossref
Christoph Bettag, Abdelhalim Hussein, Alexandra Sachkova, Hans Christoph Bock, Dorothee Mielke, Veit Rohde & Tammam Abboud. (2021) Implantation of Carmustine wafers after resection of malignant glioma with and without opening of the ventricular system. Journal of Neuro-Oncology 153:3, pages 519-525.
Crossref
Crossref
Linda Waldherr, Maria Seitanidou, Marie Jakešová, Verena Handl, Sophie Honeder, Marta Nowakowska, Tamara Tomin, Meysam Karami Rad, Tony Schmidt, Joachim Distl, Ruth Birner‐Gruenberger, Gord Campe, Ute Schäfer, Magnus Berggren, Beate Rinner, Martin Asslaber, Nassim Ghaffari‐Tabrizi‐Wizsy, Silke Patz, Daniel T. Simon & Rainer Schindl. (2021) Targeted Chemotherapy of Glioblastoma Spheroids with an Iontronic Pump. Advanced Materials Technologies 6:5, pages 2001302.
Crossref
Crossref
Taskeen Iqbal Janjua, Prarthana Rewatkar, Aria Ahmed-Cox, Iqira Saeed, Friederike M. Mansfeld, Ritu Kulshreshtha, Tushar Kumeria, David S. Ziegler, Maria Kavallaris, Roberta Mazzieri & Amirali Popat. (2021) Frontiers in the treatment of glioblastoma: Past, present and emerging. Advanced Drug Delivery Reviews 171, pages 108-138.
Crossref
Crossref
Kathryn M. Moore, Ananya B. Murthy, Elizabeth G. Graham-Gurysh, Shawn D. Hingtgen, Eric M. Bachelder & Kristy M. Ainslie. (2020) Polymeric Biomaterial Scaffolds for Tumoricidal Stem Cell Glioblastoma Therapy. ACS Biomaterials Science & Engineering 6:7, pages 3762-3777.
Crossref
Crossref
Radhika Gangaraju, Yanjun Chen, Lindsey Hageman, Jessica Wu, Liton Francisco, Michelle Kung, Emily Ness, Mariel Parman, Daniel J. Weisdorf, Stephen J. Forman, Mukta Arora, Saro H. Armenian & Smita Bhatia. (2019) Risk of venous thromboembolism in patients with non‐Hodgkin lymphoma surviving blood or marrow transplantation. Cancer 125:24, pages 4498-4508.
Crossref
Crossref
Christoph Sippl, Ralf Ketter, Luisa Braun, Fritz Teping, Louisa Schoeneberger, Yoo Jin Kim, Markus List, Arjang Nakhoda, Silke Wemmert, Joachim Oertel & Steffi Urbschat. (2019) miRNA-26a expression influences the therapy response to carmustine wafer implantation in patients with glioblastoma multiforme. Acta Neurochirurgica 161:11, pages 2299-2309.
Crossref
Crossref
Christoph Sippl, Ralf Ketter, Lisa Bohr, Yoo Jin Kim, Markus List, Joachim Oertel & Steffi Urbschat. (2019) MiRNA-181d Expression Significantly Affects Treatment Responses to Carmustine Wafer Implantation. Neurosurgery 85:1, pages 147-155.
Crossref
Crossref
Anthony Tabet, Melanie P. Jensen, Christopher C. Parkins, Parag G. Patil, Colin Watts & Oren A. Scherman. (2019) Designing Next-Generation Local Drug Delivery Vehicles for Glioblastoma Adjuvant Chemotherapy: Lessons from the Clinic. Advanced Healthcare Materials 8:3, pages 1801391.
Crossref
Crossref
Xiang Zhang, Wei Zhang, Xing-Gang Mao, Wei-Dong Cao, Hai-Ning Zhen & Shi-Jie Hu. (2019) Malignant Intracranial High Grade Glioma and Current Treatment Strategy. Current Cancer Drug Targets 19:2, pages 101-108.
Crossref
Crossref
Srishti Agarwal, Priyadharshni Muniyandi, Toru Maekawa & D. Sakthi Kumar. (2018) Vesicular systems employing natural substances as promising drug candidates for MMP inhibition in glioblastoma: A nanotechnological approach. International Journal of Pharmaceutics 551:1-2, pages 339-361.
Crossref
Crossref
Yong-Gang WangJiang LongDong-Chuan ShaoHai Song. (2018) Hyperbaric oxygen inhibits production of CD3+ T cells in the thymus and facilitates malignant glioma cell growth. Journal of International Medical Research 46:7, pages 2780-2791.
Crossref
Crossref
Enoli De Silva & Hugh Kim. (2018) Drug-induced thrombocytopenia: Focus on platelet apoptosis. Chemico-Biological Interactions 284, pages 1-11.
Crossref
Crossref
Jan Coburger, Javier Segovia von Riehm, Oliver Ganslandt, Christian Rainer Wirtz & Mirjam Renovanz. (2018) Is There an Indication for Intraoperative MRI in Subtotal Resection of Glioblastoma? A Multicenter Retrospective Comparative Analysis. World Neurosurgery 110, pages e389-e397.
Crossref
Crossref
Alf Giese, Eleftherios Archavlis & Angelika Gutenberg. 2018. Gliomchirurgie. Gliomchirurgie
77
84
.
A. Roux, F. Caire, J. Guyotat, P. Menei, P. Metellus & J. Pallud. (2017) Carmustine wafer implantation for high-grade gliomas: Evidence-based safety efficacy and practical recommendations from the Neuro-oncology Club of the French Society of Neurosurgery. Neurochirurgie 63:6, pages 433-443.
Crossref
Crossref
Jan Coburger, Mirjam Renovanz, Oliver Ganslandt, Florian Ringel, Christian Rainer Wirtz & Javier Segovia von Riehm. (2017) Evaluation of surgical decision making and resulting outcome in patients with highly eloquent glioblastoma: Results of a multicenter assessment. Clinical Neurology and Neurosurgery 162, pages 29-35.
Crossref
Crossref
Yukihiko Sonoda, Ichiyo Shibahara, Ken-ichiro Matsuda, Ryuta Saito, Tomoyuki Kawataki, Masaya Oda, Yuichi Sato, Hirokazu Sadahiro, Sadahiro Nomura, Toshio Sasajima, Takaaki Beppu, Masayuki Kanamori, Kaori Sakurada, Toshihiro Kumabe, Teiji Tominaga, Hiroyuki Kinouchi, Hiroaki Shimizu, Kuniaki Ogasawara & Michiyasu Suzuki. (2017) Opening the ventricle during surgery diminishes survival among patients with newly diagnosed glioblastoma treated with carmustine wafers: a multi-center retrospective study. Journal of Neuro-Oncology 134:1, pages 83-88.
Crossref
Crossref
Lynn S. Ashby, Kris A. Smith & Baldassarre Stea. (2016) Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review. World Journal of Surgical Oncology 14:1.
Crossref
Crossref
Satoshi Murai, Tomotsugu Ichikawa, Kazuhiko Kurozumi, Yosuke Shimazu, Tetsuo Oka, Yoshihiro Otani, Toshihiko Shimizu & Isao Date. (2016) Quantitative analysis of brain edema in patients with malignant glioma treated with BCNU wafers. Journal of Clinical Neuroscience 33, pages 148-153.
Crossref
Crossref
Yunke Bi, Lisha Liu, Yifei Lu, Tao Sun, Chen Shen, Xinli Chen, Qinjun Chen, Sai An, Xi He, Chunhui Ruan, Yinhao Wu, Yujie Zhang, Qin Guo, Zhixing Zheng, Yaohua Liu, Meiqing Lou, Shiguang Zhao & Chen Jiang. (2016) T7 Peptide-Functionalized PEG-PLGA Micelles Loaded with Carmustine for Targeting Therapy of Glioma. ACS Applied Materials & Interfaces 8:41, pages 27465-27473.
Crossref
Crossref
Pei Yang, Tingyu Liang, Chuanbao Zhang, Jinquan Cai, Wei Zhang, Baoshi Chen, Xiaoguang Qiu, Kun Yao, Guilin Li, Haoyuan Wang, Chuanlu Jiang, Gan You & Tao Jiang. (2016) Clinicopathological factors predictive of postoperative seizures in patients with gliomas. Seizure 35, pages 93-99.
Crossref
Crossref
Shiro Ohue, Shohei Kohno, Akihiro Inoue, Daisuke Yamashita, Satoshi Suehiro, Toshimoto Seno, Yoshiaki Kumon, Keiichi Kikuchi & Takanori Ohnishi. (2015) Evaluation of serial changes on computed tomography and magnetic resonance imaging after implantation of carmustine wafers in patients with malignant gliomas for differential diagnosis of tumor recurrence. Journal of Neuro-Oncology 126:1, pages 119-126.
Crossref
Crossref
Jan Coburger, Vincent Hagel, Christian Rainer Wirtz & Ralph König. (2015) Surgery for Glioblastoma: Impact of the Combined Use of 5-Aminolevulinic Acid and Intraoperative MRI on Extent of Resection and Survival. PLOS ONE 10:6, pages e0131872.
Crossref
Crossref
Sajeel A. Chowdhary, Timothy Ryken & Herbert B. Newton. (2015) Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis. Journal of Neuro-Oncology 122:2, pages 367-382.
Crossref
Crossref
S. D. Wait, R. S. Prabhu, S. H. Burri, T. G. Atkins & A. L. Asher. (2015) Polymeric drug delivery for the treatment of glioblastoma. Neuro-Oncology 17:suppl 2, pages ii9-ii23.
Crossref
Crossref
G. Huberfeld & J. Pallud. (2015) L’épilepsie associée aux tumeurs cérébrales. Pratique Neurologique - FMC 6:1, pages 19-33.
Crossref
Crossref
Ana B. Fernández, Antonio Garcia & Eglis Lazo. (2015) Malignant Cerebral Edema Secondary to Gliadel Wafers in the Early Postsurgical Period. Open Journal of Anesthesiology 05:04, pages 72-74.
Crossref
Crossref
Shunichiro Kuramitsu, Kazuya Motomura, Atsushi Natsume & Toshihiko Wakabayashi. (2015) Double-edged Sword in the Placement of Carmustine (BCNU) Wafers along the Eloquent Area: A Case Report. NMC Case Report Journal 2:1, pages 40-45.
Crossref
Crossref
Kimitoshi SATO, Mitsuru DAN, Daisuke YAMAMOTO, Yoshiteru MIYAJIMA, Atsuko HARA & Toshihiro KUMABE. (2015) Chronic Phase Intracranial Hemorrhage Caused by Ruptured Pseudoaneurysm Induced by Carmustine Wafer Implantation for Insulo-opercular Anaplastic Astrocytoma: A Case Report. Neurologia medico-chirurgica 55:11, pages 848-851.
Crossref
Crossref
Ke Sai, Ming-gu Zhong, Jian Wang, Yin-sheng Chen, Yong-gao Mou, Chao Ke, Xiang-heng Zhang, Qun-ying Yang, Fu-hua Lin, Cheng-cheng Guo, Zheng-he Chen, Jing Zeng, Yan-chun Lv, Xiang Li, Wen-chang Gao & Zhong-ping Chen. (2014) Safety evaluation of high-dose BCNU-loaded biodegradable implants in Chinese patients with recurrent malignant gliomas. Journal of the Neurological Sciences 343:1-2, pages 60-65.
Crossref
Crossref
Kieron J. Sweeney, Monika A. Jarzabek, Patrick Dicker, Donncha F. O’Brien, John J. Callanan, Annette T. Byrne & Jochen H.M. Prehn. (2014) Validation of an imageable surgical resection animal model of Glioblastoma (GBM). Journal of Neuroscience Methods 233, pages 99-104.
Crossref
Crossref
Maria Angela Samis Zella, Marta Wallocha, Philipp J. Slotty, Gueler Isik, Daniel Hänggi, Juliane Schroeteler, Christian Ewelt, Hans-Jakob Steiger & Michael Sabel. (2013) Evaluation of post-operative complications associated with repeat resection and BCNU wafer implantation in recurrent glioblastoma. Acta Neurochirurgica 156:2, pages 313-323.
Crossref
Crossref
E. Curfman, M. Jiang & M.G. Soni. 2014. Encyclopedia of Toxicology. Encyclopedia of Toxicology
374
376
.
Katharine A McNeill & Howard A Fine. (2013) Challenges in clinical trial design for recurrent glioblastoma. Clinical Investigation 3:9, pages 835-848.
Crossref
Crossref
Sara Fritzell, Emma Sandén, Sofia Eberstål, Edward Visse, Anna Darabi & Peter Siesjö. (2013) Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion. Cancer Immunology, Immunotherapy 62:9, pages 1463-1474.
Crossref
Crossref
Julien Duntze, Claude-Fabien Litré, Christophe Eap, Etienne Théret, Adeline Debreuve, Nicolas Jovenin, Emmanuèle Lechapt-Zalcman, Philippe Metellus, Philippe Colin, Jean-Sébastien Guillamo, Evelyne Emery, Philippe Menei, Pascal Rousseaux & Philippe Peruzzi. (2012) Implanted Carmustine Wafers Followed by Concomitant Radiochemotherapy to Treat Newly Diagnosed Malignant Gliomas: Prospective, Observational, Multicenter Study on 92 Cases. Annals of Surgical Oncology 20:6, pages 2065-2072.
Crossref
Crossref
A. Gutenberg, C. B. Lumenta, W. E. K. Braunsdorf, M. Sabel, H. M. Mehdorn, M. Westphal & A. Giese. (2013) The combination of carmustine wafers and temozolomide for the treatment of malignant gliomas. A comprehensive review of the rationale and clinical experience. Journal of Neuro-Oncology 113:2, pages 163-174.
Crossref
Crossref
Lutz Dörner, Ahmad Mustafa, Axel Rohr, H. Maximilian Mehdorn & Arya Nabavi. (2013) Growth pattern of tumor recurrence following bis-chloroethylnitrosourea (BCNU) wafer implantation in malignant glioma. Journal of Clinical Neuroscience 20:3, pages 429-434.
Crossref
Crossref
Petra Miglierini, Mohamed Bouchekoua, Benoit Rousseau, Phong Dam Hieu, Jean-Pierre Malhaire & Olivier Pradier. (2012) Impact of the per-operatory application of GLIADEL wafers (BCNU, carmustine) in combination with temozolomide and radiotherapy in patients with glioblastoma multiforme: Efficacy and toxicity. Clinical Neurology and Neurosurgery 114:9, pages 1222-1225.
Crossref
Crossref
Kevin Anton, Joachim M. Baehring & Tina Mayer. (2012) Glioblastoma Multiforme. Hematology/Oncology Clinics of North America 26:4, pages 825-853.
Crossref
Crossref
Pasquale De Bonis, Carmelo Anile, Angelo Pompucci, Alba Fiorentino, Mario Balducci, Silvia Chiesa, Giulio Maira & Annunziato Mangiola. (2012) Safety and efficacy of Gliadel wafers for newly diagnosed and recurrent glioblastoma. Acta Neurochirurgica 154:8, pages 1371-1378.
Crossref
Crossref
Tetsuya Ozeki, Daiki Kaneko, Kosuke Hashizawa, Yoshihiro Imai, Tatsuaki Tagami & Hiroaki Okada. (2012) Improvement of survival in C6 rat glioma model by a sustained drug release from localized PLGA microspheres in a thermoreversible hydrogel. International Journal of Pharmaceutics 427:2, pages 299-304.
Crossref
Crossref
S. Ulmer, K. Spalek, A. Nabavi, S. Schultka, H. M. Mehdorn, S. Kesari & L. Dorner. (2012) Temporal changes in magnetic resonance imaging characteristics of Gliadel wafers and of the adjacent brain parenchyma. Neuro-Oncology 14:4, pages 482-490.
Crossref
Crossref
Gregorio Catalán-Uribarrena, Gaizka Bilbao-Barandica, Iñigo Pomposo-Gaztelu, José Undabeitia-Huertas, Edurne Ruiz de Gopegui-Ruiz, Lara Galbarriatu-Gutiérrez, Manuel Canales-Llantada, Jon Aurrecoechea-Obieta, Alfonso Igartua-Azkune & Guillermo Carbayo-Lozano. (2011) Prognostic factors and survival in a prospective cohort of patients with high-grade glioma treated with carmustine wafers or temozolomide on an intention-to-treat basis. Acta Neurochirurgica 154:2, pages 211-222.
Crossref
Crossref
Robert Loch Macdonald, Ming Leung & Tom Tice. (2012) Intracranial drug delivery for subarachnoid hemorrhage. Therapeutic Delivery 3:1, pages 91-103.
Crossref
Crossref
Atom Sarkar & E. Antonio Chiocca. 2012. Brain Tumors. Brain Tumors
384
407
.
Alessandro Della Puppa, Luca Denaro, Marta Rossetto, Pietro Ciccarino, Renzo Manara, Giuseppe Lombardi, Giulia Del Moro, Antonino Rotilio, Domenico d’Avella & Renato Scienza. (2011) Postoperative seizure in high grade glioma patients treated with BCNU wafers. A mono-institutional experience. Journal of Neuro-Oncology 105:2, pages 275-280.
Crossref
Crossref
Andrea Salmaggi, Stefania Duri, Antonio Silvani, Paola Gaviani, Ida Milanesi, Cecilia Casali & Francesco Di Meco. (2011) Loco-regional treatments in first-diagnosis glioblastoma: literature review on association between Stupp protocol and Gliadel. Neurological Sciences 32:S2, pages 241-245.
Crossref
Crossref
Alessandro Della Puppa, Marta Rossetto, Pietro Ciccarino, Luca Denaro, Antonino Rotilio, Domenico d'Avella & Renato Scienza. (2011) Carmustine Wafer Implantation When Surgical Cavity Is Communicating with Cerebral Ventricles: Technical Considerations on a Clinical Series. World Neurosurgery 76:1-2, pages 156-159.
Crossref
Crossref
Matthias Preusser, Sandrine de Ribaupierre, Adelheid Wöhrer, Sara C. Erridge, Monika Hegi, Michael Weller & Roger Stupp. (2011) Current concepts and management of glioblastoma. Annals of Neurology 70:1, pages 9-21.
Crossref
Crossref
Lutz Dörner, Stephan Ulmer, Axel Rohr, H. Maximilian Mehdorn & Arya Nabavi. (2011) Space-occupying cyst development in the resection cavity of malignant gliomas following Gliadel® implantation – incidence, therapeutic strategies, and outcome. Journal of Clinical Neuroscience 18:3, pages 347-351.
Crossref
Crossref
Hans Christoph Bock, Joseph Cohnen, Naureen Keric, Sven Rainer Kantelhardt & Alf Giese. (2011) Occlusion of surgical opening of the ventricular system with fibrinogen-coated collagen fleece: a case collection study. Acta Neurochirurgica 153:3, pages 533-539.
Crossref
Crossref
Jeffrey Raizer. (2010) Issues in Developing Drugs for Primary Brain Tumors: Barriers and Toxicities. Toxicologic Pathology 39:1, pages 152-157.
Crossref
Crossref
Frederick G. BarkerIIII. 2011. Youmans Neurological Surgery. Youmans Neurological Surgery
1243
1253
.
Ciro Parlato, Giuseppe di Nuzzo, Marianna Luongo, Raffaele Stefano Parlato, Marina Accardo, Luigi Cuccurullo & Aldo Moraci. (2010) Use of a collagen biomatrix (TissuDura®) for dura repair: a long-term neuroradiological and neuropathological evaluation. Acta Neurochirurgica 153:1, pages 142-147.
Crossref
Crossref
Alessandro Della Puppa, Marta Rossetto, Pietro Ciccarino, Giulia Del Moro, Antonino Rotilio, Renzo Manara, Marina Paola Gardiman, Luca Denaro, Domenico d’Avella & Renato Scienza. (2010) The first 3 months after BCNU wafers implantation in high-grade glioma patients: clinical and radiological considerations on a clinical series. Acta Neurochirurgica 152:11, pages 1923-1931.
Crossref
Crossref
Hans Christoph Bock, Maximilian Josef Anton Puchner, Frauke Lohmann, Michael Schütze, Simone Koll, Ralf Ketter, Ruediger Buchalla, Nikolai Rainov, Sven R. Kantelhardt, Veit Rohde & Alf Giese. (2010) First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience. Neurosurgical Review 33:4, pages 441-449.
Crossref
Crossref
M. Westphal & W. Stummer. (2010) Lokale Therapien bei hirneigenen TumorenLocal therapy of primary brain tumors. Der Nervenarzt 81:8, pages 913-917.
Crossref
Crossref
Anne Balossier, Lutz Dörner, Evelyne Emery, Oliver Heese, H. Maximilian Mehdorn, Philippe Menei & Jagmohan Singh. (2010) Incorporating BCNU Wafers into Malignant Glioma Treatment. Clinical Drug Investigation 30:3, pages 195-204.
Crossref
Crossref
. (2009) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 18:5.
Crossref
Crossref